Skip to main content
. 2017 Feb 28;8(12):19843–19854. doi: 10.18632/oncotarget.15773

Figure 3.

Figure 3

Western blot demonstrating the effects of different treatment on the protein levels of sodium iodine symporter (NIS), thyroglobulin (Tg), thyroid-stimulating hormone receptor (TSHR), thyroid peroxidase (TPO), glucose transporter-1 (GLUT1) in BCPAP (left) and K1 (right) cells. Cells were treated with 0.1 μM dabrafenib alone or in combination with 1 μM lapatinib. β-actin was used as positive control.